Mouse IL-1 beta / IL-1F2 Protein, His Tag (MALS verified)
分子別名(Synonym)
IL1B,IL-1BETA,IL1F2,IL-1β
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Mouse IL-1 beta, His Tag (ILB-M51H3) is expressed from E. coli cells. It contains AA Val 118 - Ser 269 (Accession # P10749-1).
Predicted N-terminus: Met
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a polyhistidine tag at the N-terminus.
The protein has a calculated MW of 19.3 kDa. The protein migrates as 19-20 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE).
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
白細(xì)胞介素-1β(IL-1β)也稱為分解代謝素,是一種細(xì)胞因子蛋白,在人類中由IL1B基因編碼。IL-1β前體被胱天蛋白酶1(白細(xì)胞介素1β轉(zhuǎn)化酶)切割。胞漿巰基蛋白酶裂解產(chǎn)物形成成熟的IL-1β。
IL1β是結(jié)構(gòu)相關(guān)的多肽,在人類中具有約21%的氨基酸(aa)同一性。這兩種蛋白質(zhì)都是由各種各樣的細(xì)胞在炎癥因子、感染或微生物內(nèi)毒素的作用下產(chǎn)生的。雖然IL1α和IL1β是獨(dú)立調(diào)節(jié)的,但它們與相同的受體結(jié)合并發(fā)揮相同的生物學(xué)作用。
IL-1β是白細(xì)胞介素1細(xì)胞因子家族的成員。這種細(xì)胞因子是由活化的巨噬細(xì)胞作為前蛋白產(chǎn)生的,前蛋白被胱天蛋白酶1(CASP1/ICE)蛋白水解加工成其活性形式。這種細(xì)胞因子是炎癥反應(yīng)的重要介質(zhì),參與多種細(xì)胞活動(dòng),包括細(xì)胞增殖、分化和凋亡。發(fā)現(xiàn)這種細(xì)胞因子在中樞神經(jīng)系統(tǒng)(CNS)中誘導(dǎo)環(huán)氧化酶-2(PTGS2/COX2)會(huì)導(dǎo)致炎癥性疼痛超敏反應(yīng)。該基因和其他八個(gè)白細(xì)胞介素1家族基因在2號(hào)染色體上形成細(xì)胞因子基因簇。
關(guān)鍵字: IL-1 beta;IL-1 beta蛋白;IL-1 beta重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。